These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16498394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F, Wu L, He Q, Zhang Z, Chang C, Li X.
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
    Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M.
    Leukemia; 2005 May; 19(5):776-83. PubMed ID: 15789068
    [Abstract] [Full Text] [Related]

  • 5. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
    Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, Hellström-Lindberg E.
    Blood; 2005 Jul 01; 106(1):247-53. PubMed ID: 15755901
    [Abstract] [Full Text] [Related]

  • 6. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
    Violidaki D, Axler O, Jafari K, Bild F, Nilsson L, Mazur J, Ehinger M, Porwit A.
    Cytometry B Clin Cytom; 2020 Sep 01; 98(5):399-411. PubMed ID: 32543774
    [Abstract] [Full Text] [Related]

  • 7. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Kárai B, Bedekovics J, Miltényi Z, Gergely L, Szerafin L, Ujfalusi A, Kappelmayer J, Hevessy Z.
    Int J Lab Hematol; 2017 Dec 01; 39(6):577-584. PubMed ID: 28625017
    [Abstract] [Full Text] [Related]

  • 8. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
    Li J, He GS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug 01; 21(4):1069-72. PubMed ID: 23998614
    [Abstract] [Full Text] [Related]

  • 9. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
    Eidenschink Brodersen L, Menssen AJ, Wangen JR, Stephenson CF, de Baca ME, Zehentner BK, Wells DA, Loken MR.
    Cytometry B Clin Cytom; 2015 Mar 01; 88(2):125-35. PubMed ID: 25490867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG, Lanza F, Del Vecchio L, Italian Society of Cytometry (GIC).
    Cytometry B Clin Cytom; 2011 Mar 01; 80(4):201-11. PubMed ID: 21674774
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A, Pati H, Mahapatra M, Mishra P, Seth T, Kumar S, Singh S, Pandey S, Kumar R.
    Ann Hematol; 2012 Sep 01; 91(9):1351-62. PubMed ID: 22526362
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
    Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME.
    Blood; 2001 Aug 15; 98(4):979-87. PubMed ID: 11493442
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
    Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P.
    Blood; 2003 Mar 01; 101(5):1996-2000. PubMed ID: 12406866
    [Abstract] [Full Text] [Related]

  • 19. High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.
    Riabov V, Mossner M, Stöhr A, Jann JC, Streuer A, Schmitt N, Knaflic A, Nowak V, Weimer N, Obländer J, Palme I, Schumann C, Baldus CD, Schulze TJ, Wuchter P, Röhl H, Jawhar A, Weiss C, Boch T, Metzgeroth G, Neumann M, Hofmann WK, Nolte F, Nowak D.
    Br J Haematol; 2021 Mar 01; 192(5):879-891. PubMed ID: 33486765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.